Literature DB >> 15708116

Inhibition of lymphocyte proliferation and activation: a mechanism used by equine invasive trophoblast to escape the maternal immune response.

M J B F Flaminio1, D F Antczak.   

Abstract

At days 36-38 of gestation, the equine invasive trophoblast cells migrate into the endometrium of the pregnant mare to form the endometrial cups. During their migration, they become surrounded by maternal CD4+ and CD8+ T lymphocytes, and stimulate a cytotoxic antibody response to the paternal major histocompatibility complex class I antigens that they express. Nevertheless, endometrial cup cells remain viable at the site of uterine invasion up to days 80-100 of gestation, suggesting the participation of immunomodulatory mechanisms to the maternal cellular immune response. To determine the effects of the invasive trophoblast cells on lymphocyte proliferation, an in vitro co-culture system was developed using isolated equine invasive trophoblast cells and peripheral blood lymphocytes. Fetal fibroblast cells from the same conceptuses were used as controls. The presence of invasive trophoblast cells or their pre-conditioned medium inhibited 50% or more of lymphocyte proliferation, while fetal fibroblasts had no effect. The invasive trophoblast cell inhibitory factor needed to be present constantly to affect lymphocyte proliferation, and it was ineffective if lymphocytes had been previously stimulated to proliferate. The lymphoproliferative inhibitory mechanism affected lymphocyte subpopulations similarly. In addition, lymphocyte expression of cytokine mRNA including IFNgamma, IL-2, IL-4, and IL-10 was affected compared to controls. The implication of these observations in vivo may explain, in part, the apparent equine maternal immune acceptance of the presence and development of endometrial cup cells. (c) Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708116     DOI: 10.1016/j.placenta.2004.05.008

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  12 in total

1.  Functions of ectopically transplanted invasive horse trophoblast.

Authors:  Amanda M de Mestre; David Hanlon; A Paige Adams; Erin Runcan; Jane C Leadbeater; Hollis N Erb; Christina C Costa; Donald Miller; W R Allen; Douglas F Antczak
Journal:  Reproduction       Date:  2011-03-09       Impact factor: 3.906

2.  IL-22 is expressed by the invasive trophoblast of the equine (Equus caballus) chorionic girdle.

Authors:  Margaret M Brosnahan; Donald C Miller; Mackenzie Adams; Douglas F Antczak
Journal:  J Immunol       Date:  2012-04-04       Impact factor: 5.422

3.  Split immunological tolerance to trophoblast.

Authors:  Amanda de Mestre; Leela Noronha; Bettina Wagner; Douglas F Antczak
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

4.  Placentation in Equids.

Authors:  Douglas F Antczak; W R Twink Allen
Journal:  Adv Anat Embryol Cell Biol       Date:  2021       Impact factor: 1.231

5.  Effects of hypoxia inducible factors-1α on autophagy and invasion of trophoblasts.

Authors:  Jong-Ho Choi; Hyun-Jung Lee; Tae-Hyun Yang; Gi Jin Kim
Journal:  Clin Exp Reprod Med       Date:  2012-06-30

Review 6.  Immunologic regulation in pregnancy: from mechanism to therapeutic strategy for immunomodulation.

Authors:  Shyi-Jou Chen; Yung-Liang Liu; Huey-Kang Sytwu
Journal:  Clin Dev Immunol       Date:  2011-11-03

7.  The effect of CpG-ODN on antigen presenting cells of the foal.

Authors:  M Julia B F Flaminio; Alexandre S Borges; Daryl V Nydam; David W Horohov; Rolf Hecker; Mary Beth Matychak
Journal:  J Immune Based Ther Vaccines       Date:  2007-01-25

8.  Changes in Blood Lymphocyte Subpopulations and Expression of MHC-II Molecules in Wild Mares Before and After Parturition.

Authors:  Leszek Krakowski; Przemysław Bartoszek; Izabela Krakowska; Anna Stachurska; Tomasz Piech; Piotr Brodzki; Zygmunt Wrona
Journal:  J Vet Res       Date:  2017-12-06       Impact factor: 1.744

9.  Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro.

Authors:  Lauren V Schnabel; Lynn M Pezzanite; Douglas F Antczak; M Julia Bevilaqua Felippe; Lisa A Fortier
Journal:  Stem Cell Res Ther       Date:  2014-01-24       Impact factor: 6.832

Review 10.  Major histocompatibility complex I mediates immunological tolerance of the trophoblast during pregnancy and may mediate rejection during parturition.

Authors:  Anna Rapacz-Leonard; Małgorzata Dąbrowska; Tomasz Janowski
Journal:  Mediators Inflamm       Date:  2014-04-09       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.